Esophageal Neoplasms: all 1,631 studies
Page 13 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Length of the Proximal Resection Margin for Siewert-II/Siewert-III TumorsStatus unknownNCT02313688Not applicable
- Non-endoscopic EC Screening Program in Northern IranSuspendedNCT02311712Not applicable
- Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIEStatus unknownNCT02309619Not applicable
- Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in FranceApproved for marketingNCT02307812
- Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric CancerCompletedNCT02305043
- Routine Post-Operative Supplemental NutritionTerminatedNCT02297607Not applicable
- Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume DefinitionStatus unknownNCT02285660Not applicable
- Early Detection of Tumors of the Digestive Tract by Confocal EndomicroscopyCompletedNCT02284802Not applicable
- Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal CarcinomaStatus unknownNCT02279134Phase 2/3
- Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line TreatmentWithdrawnNCT02274012Phase 2
- The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)CompletedNCT02273713Phase 1/2
- Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal CancerCompletedNCT02253602Not applicable
- Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.CompletedNCT02241499Phase 2
- Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer PatientsTerminatedNCT02221245
- Effects of S-1 and Capecitabine on Coronary Artery Blood FlowTerminatedNCT02216149Phase 2
- Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal CancerActive, not recruitingNCT02213497Phase 1
- Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric AdenocarcinomaStatus unknownNCT02193594Phase 2/3
- Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal CancerStatus unknownNCT02188615Phase 2
- Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric AdenocarcinomaStatus unknownNCT02177552Phase 2
- POsitioning for Esophageal Cancer ResectionTerminatedNCT02157363Not applicable
- Endoscopic Prevention of Esophageal Cancer at Tenwek HospitalSuspendedNCT02146508Not applicable
- Organ Motion and Early Tumor Response MeasurementCompletedNCT02139488
- LDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaCompletedNCT02138929Phase 1
- Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell CarcinomaCompletedNCT02133612Phase 2
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedNCT02128243Phase 2
- PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal CancerCompletedNCT02125448
- Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal CarcinomaCompletedNCT02120911Phase 1/2
- Endoscopic Screening on Esophageal CancerCompletedNCT02094105Not applicable
- Angiogenic Factor Expression During Fractionated IrradiationStatus unknownNCT02072720Early Phase 1
- Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02041819Phase 2
- FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaActive, not recruitingNCT02037048Phase 2
- Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWithdrawnNCT02034968Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal CancerCompletedNCT02030769Not applicable
- A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal CancerCompletedNCT02027948Not applicable
- FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal CarcinomaCompletedNCT02023593Phase 2
- Proton Beam Therapy to Treat Esophageal CancerTerminatedNCT02023541Phase 1
- A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the EsophagusTerminatedNCT02017600Phase 2
- Design of the EFECTS TrialWithdrawnNCT02017366Not applicable
- Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal CancerStatus unknownNCT02017002Not applicable
- A Study of DKN-01 in Combination With Paclitaxel or PembrolizumabCompletedNCT02013154Phase 1
- Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal CarcinomaWithdrawnNCT02011594Phase 2
- Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal CancerWithdrawnNCT01998347Phase 3
- Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal CancerCompletedNCT01998230Phase 3
- Adverse Events During Upper Gastrointestinal EndoscopyStatus unknownNCT01979549
- Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric JunctionCompletedNCT01962246Phase 2/3
- Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.Status unknownNCT01959906
- PLA for HCC and Esophageal ca SerumStatus unknownNCT01957241
- Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer PatientCompletedNCT01952210Not applicable
- Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal CancerCompletedNCT01950442Not applicable
- Comparable Study of Different Radiation Dose in Esophageal CarcinomaStatus unknownNCT01937208Phase 3
- ESI With EUS to Differentiate T3 and T4 ESCCStatus unknownNCT01930630Phase 1
- Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal CancerStatus unknownNCT01927978
- Iron Replacement in Oesophagogastric NeoplasiaStatus unknownNCT01927328Phase 4
- Outcomes After Esophageal Cancer SurgeryCompletedNCT01927016
- ROCS (Radiotherapy After Oesophageal Cancer Stenting) StudyCompletedNCT01915693Phase 3
- Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric CancersStatus unknownNCT01911832Phase 3
- Adaptive Pet StudyCompletedNCT01908504Not applicable
- Home Jejunostomy Feeding Following Esophagectomy/GastrectomyCompletedNCT01870817Not applicable
- Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric CancerTerminatedNCT01870791Phase 2
- Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal CancerCompletedNCT01858805
- Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISHCompletedNCT01855854Phase 2
- A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal CancerStatus unknownNCT01843829Phase 2
- Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal CancerStatus unknownNCT01843049Phase 1/2
- Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal CancerCompletedNCT01836913
- Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric CancerTerminatedNCT01830270Phase 2
- NIR-Guided Sentinel Lymph-Node Mapping for Esophageal CancerCompletedNCT01808417Phase 1
- Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)CompletedNCT01807936Not applicable
- Perspectives of Receiving Open Versus Minimally Invasive SurgeryStatus unknownNCT01807390
- BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line ChemotherapyTerminatedNCT01806649Phase 2
- trūFreeze® Spray Cryotherapy Patient RegistryCompletedNCT01802203
- Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction CancerStatus unknownNCT01786278Phase 2/3
- Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal CarcinomaCompletedNCT01783158
- Esophageal Cancer Tissue BankingCompletedNCT01780961
- UICC Classification of Esophageal CancerCompletedNCT01770275
- Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer PatientsCompletedNCT01766349
- Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;Status unknownNCT01745107Phase 3
- Quality of Life After Esophagectomy for Cancer - Step 2TerminatedNCT01738633Not applicable
- Quality of Life After Esophagectomy for Cancer - Step 1TerminatedNCT01738620Not applicable
- A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal CancerStatus unknownNCT01732380Phase 2
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Phase I Platinum Based Chemotherapy Plus IndomethacinCompletedNCT01719926Phase 1
- A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal CancerCompletedNCT01710592Phase 2
- Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
- Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal CancerTerminatedNCT01704690Phase 2/3
- Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal LesionsStatus unknownNCT01698190Not applicable
- Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric JunctionStatus unknownNCT01697917Phase 3
- Docetaxel and S-1 for Advanced Esophageal CancerStatus unknownNCT01693432Phase 2
- Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal CancerStatus unknownNCT01691664Not applicable
- Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal CancerCompletedNCT01691625Not applicable
- Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)Active, not recruitingNCT01688908Not applicable
- Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal CancerCompletedNCT01670409Phase 2
- The Effect of Parenteral Nutrition Supplement on Esophagectomy PatientsCompletedNCT01669356Not applicable
- Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal CancerStatus unknownNCT01646853Not applicable
- Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal CancerCompletedNCT01640860
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Nodal Status in Adenocarcinoma of the Esophagus an CardiaCompletedNCT01635595
- IMRT/Pemetrexed/Cisplatin in Esophageal CancerStatus unknownNCT01630174
- Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and RadiationWithdrawnNCT01627080
- Imaging Study Compare 4DCT ImageCompletedNCT01626001Phase 1